Jiangtao Li

机构：Isfahan University of Medical Sciences · ORCID：0000-0001-7538-2910

发表论文 192 篇 · 总被引 1560 次 · h-index 20

代表论文

• Chinese expert consensus on sequential surgery following conversion therapy based on combination of immune checkpoint inhibitors and antiangiogenic targeted drugs for advanced hepatocellular carcinoma (2024 edition) (2024 · BioScience Trends · 被引 20)
• Preoperative prediction of textbook outcome in intrahepatic cholangiocarcinoma by interpretable machine learning: A multicenter cohort study (2025 · World Journal of Gastroenterology · 被引 15)
• RETRACTED: Construction and drug screening of Co-culture system using extrahepatic cholangiocarcinoma organoids and tumor-associated macrophages (2024 · Heliyon · 被引 8)
• Efficacy and safety of venetoclax and azacitidine for acute myeloid leukemia in China: a real-world single-center study (2025 · BMC Cancer · 被引 7)
• Applications and challenges of patient-derived organoids in hepatobiliary and pancreatic cancers (2025 · World Journal of Gastroenterology · 被引 7)
• A comprehensive analysis of molecular characteristics of hot and cold tumor of gastric cancer (2025 · Cancer Immunology Immunotherapy · 被引 5)